Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF)
- 15 April 2009
- journal article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 116 (10), 781-789
- https://doi.org/10.1042/cs20080372
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Interleukin-6 and atrial fibrillation in patients with coronary artery disease: Data from the Heart and Soul StudyAmerican Heart Journal, 2007
- Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?Stroke, 2007
- Additive Role of Plasma von Willebrand Factor Levels to Clinical Factors for Risk Stratification of Patients With Atrial FibrillationStroke, 2006
- Intraindividual temporal variance of biomarkers and the definition of individualized prognosis in cardiovascular patients.Journal of Human Hypertension, 2006
- Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillationThrombosis Research, 2005
- Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillationAmerican Heart Journal, 2004
- Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.The American Journal of Cardiology, 1998
- Fibrin d -Dimer and β-Thromboglobulin as Markers of Thrombogenesis and Platelet Activation in Atrial FibrillationCirculation, 1996
- Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: Evidence for intermediate elevated levels of intravascular thrombogenesisAmerican Heart Journal, 1996
- The 1993 Guidelines for the Management of Mild Hypertension: Memorandum from a WHO/ISH MeetingBlood Pressure, 1993